scispace - formally typeset
H

Harpal S. Buttar

Researcher at University of Ottawa

Publications -  105
Citations -  1868

Harpal S. Buttar is an academic researcher from University of Ottawa. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 85 publications receiving 1351 citations. Previous affiliations of Harpal S. Buttar include Health and Welfare Canada & Guru Nanak Dev University.

Papers
More filters
Journal Article

Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation.

TL;DR: The present review is to evaluate and compare the results of epidemiological, experimental and clinical studies, reporting on the influence of physical activity, dietary intervention, obesity and cigarette smoking on cardiovascular health and the prevention of CVDs.
Journal ArticleDOI

Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention.

TL;DR: Sustained oxidative stress leading to inflammation and thence to cancer and cardiovascular disease is described for spices and herbs, using curcumin as an example of an intervention, based on activation of transcription factors which suggest that oxidative stress, chronic inflammation, and cancer are closely linked.
Journal ArticleDOI

The Role of Food Antioxidants, Benefits of Functional Foods, and Influence of Feeding Habits on the Health of the Older Person: An Overview

TL;DR: This overview was directed towards understanding the relationship of brain functions with dietary choices mainly by older humans, as they relate to dietary sufficiency or the association of antioxidants with neurodegenerative diseases such as dementia and Alzheimer’s disease.
Journal ArticleDOI

Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy.

TL;DR: The intent of this review is to highlight the in vitro and in vivo activities of fisetin and to provide up‐to‐date information about the molecular interactions of f isetin with its cellular targets involved in cancer initiation, promotion and progression as well as to focus on strategies underway to increase the bioavailability and reduce the risk of deleterious effects, if any, associated with fisettin administration.
Book ChapterDOI

An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development

TL;DR: The purpose of this review is to briefly discuss the pathophysiological role of the reninangiotensin system, the therapeutic uses of ACE inhibitors in pregnant patients and to focus primarily on the major fetotoxic effects ofACE inhibitors encountered in humans and animal models.